Maryse Guéguen

Immunologic Analysis of a Phase I/II Study of Vaccination with MAGE-3 Protein Combined with the AS02B Adjuvant in Patients with MAGE-3-Positive Tumors

Valérie Vantomme, Christine Dantinne, Noreddine Amrani et al. · Journal of Immunotherapy · 2004 · 87 citations

Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody

Maryse Guéguen, Odile Boniface, Olivier Bernard et al. · Journal of Autoimmunity · 1991 · 75 citations

Hepatology, Biochemistry, Medicine +8

Anti-liver kidney microsome antibody type 1 recognizes human cytochrome P450 db1

Maryse Guéguen, Ana Maria Yamamoto, O. Bernard et al. · Biochemical and Biophysical Research Communications · 1989 · 72 citations

Medicine, Liver Physiology, Bioanalysis +6

An Antigen Recognized by Autologous CTLs on a Human Bladder Carcinoma

Maryse Guéguen, Jean‐Jacques Patard, Béatrice Gaugler et al. · The Journal of Immunology · 1998 · 69 citations

Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen

Maryse Guéguen, Eric O. Long · Proceedings of the National Academy of Sciences · 1996 · 52 citations · Full text

Histocompatibility, Long-lived Form, Class Ii Molecules +15